Literature DB >> 27708270

INPPL1 gene mutations in opsismodysplasia.

Anaïs Fradet1, Jamie Fitzgerald1.   

Abstract

The INPPL1 (inositol polyphosphate phosphatase-like 1) gene encodes the inositol phosphatase, SHIP2 (for src homology 2 domain-containing inositol phosphatase 2). SHIP2 functions to dephosphorylate, and negatively regulate, the lipid second messenger phosphatidylinositol (3,4,5)P3. SHIP2 has been well studied in the area of insulin resistance and obesity but has roles in cancer and other disorders. Recently, it was reported that mutations in INPPL1 cause opsismodysplasia, a rare, autosomal recessive severe skeletal dysplasia. This review focuses on the mutations associated with opsismodysplasia and explores the role of INPPL1/ SHIP2 in skeletal development.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27708270      PMCID: PMC5268411          DOI: 10.1038/jhg.2016.119

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  54 in total

1.  Atlanto-axial segmentation defects and os odontoideum in two male siblings with opsismodysplasia.

Authors:  Ali Al Kaissi; Farid Ben Chehida; Maher Ben Ghachem; Franz Grill; Klaus Klaushofer
Journal:  Skeletal Radiol       Date:  2008-12-03       Impact factor: 2.199

Review 2.  The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases.

Authors:  Katrien Backers; Daniel Blero; Nathalie Paternotte; Jing Zhang; Christophe Erneux
Journal:  Adv Enzyme Regul       Date:  2003

3.  Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity.

Authors:  Mark W Sleeman; Katherine E Wortley; Ka-Man V Lai; Lori C Gowen; Jennifer Kintner; William O Kline; Karen Garcia; Trevor N Stitt; George D Yancopoulos; Stanley J Wiegand; David J Glass
Journal:  Nat Med       Date:  2005-01-16       Impact factor: 53.440

4.  Whole-genome analysis reveals that mutations in inositol polyphosphate phosphatase-like 1 cause opsismodysplasia.

Authors:  Jennifer E Below; Dawn L Earl; Kathryn M Shively; Margaret J McMillin; Joshua D Smith; Emily H Turner; Mark J Stephan; Lihadh I Al-Gazali; Jozef L Hertecant; David Chitayat; Sheila Unger; Daniel H Cohn; Deborah Krakow; James M Swanson; Elaine M Faustman; Jay Shendure; Deborah A Nickerson; Michael J Bamshad
Journal:  Am J Hum Genet       Date:  2012-12-27       Impact factor: 11.025

5.  SHIP2, a factor associated with diet-induced obesity and insulin sensitivity, attenuates FGF signaling in vivo.

Authors:  Michael J Jurynec; David Jonah Grunwald
Journal:  Dis Model Mech       Date:  2010-07-08       Impact factor: 5.758

Review 6.  SHIP2 multiple functions: a balance between a negative control of PtdIns(3,4,5)P₃ level, a positive control of PtdIns(3,4)P₂ production, and intrinsic docking properties.

Authors:  Christophe Erneux; William's Elong Edimo; Laurence Deneubourg; Isabelle Pirson
Journal:  J Cell Biochem       Date:  2011-09       Impact factor: 4.429

7.  Nucleotide-sugar transporter SLC35D1 is critical to chondroitin sulfate synthesis in cartilage and skeletal development in mouse and human.

Authors:  Shuichi Hiraoka; Tatsuya Furuichi; Gen Nishimura; Shunichi Shibata; Masaki Yanagishita; David L Rimoin; Andrea Superti-Furga; Peter G Nikkels; Minako Ogawa; Kayoko Katsuyama; Hidenao Toyoda; Akiko Kinoshita-Toyoda; Nobuhiro Ishida; Kyoichi Isono; Yutaka Sanai; Daniel H Cohn; Haruhiko Koseki; Shiro Ikegawa
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

8.  The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man.

Authors:  Evelyne Marion; Pamela Jane Kaisaki; Valérie Pouillon; Cyril Gueydan; Jonathan C Levy; André Bodson; Georges Krzentowski; Jean-Claude Daubresse; Jean Mockel; Jens Behrends; Geneviève Servais; Claude Szpirer; Véronique Kruys; Dominique Gauguier; Stéphane Schurmans
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

9.  The inositol 5-phosphatase SHIP2 is an effector of RhoA and is involved in cell polarity and migration.

Authors:  Katsuhiro Kato; Tsubasa Yazawa; Kentaro Taki; Kazutaka Mori; Shujie Wang; Tomoki Nishioka; Tomonari Hamaguchi; Toshiki Itoh; Tadaomi Takenawa; Chikako Kataoka; Yoshiharu Matsuura; Mutsuki Amano; Toyoaki Murohara; Kozo Kaibuchi
Journal:  Mol Biol Cell       Date:  2012-05-16       Impact factor: 4.138

10.  SHIP2 regulates epithelial cell polarity through its lipid product, which binds to Dlg1, a pathway subverted by hepatitis C virus core protein.

Authors:  Aline Awad; Sokhavuth Sar; Ronan Barré; Clotilde Cariven; Mickael Marin; Jean Pierre Salles; Christophe Erneux; Didier Samuel; Ama Gassama-Diagne
Journal:  Mol Biol Cell       Date:  2013-05-22       Impact factor: 4.138

View more
  4 in total

Review 1.  The impact of phosphoinositide 5-phosphatases on phosphoinositides in cell function and human disease.

Authors:  Ana Raquel Ramos; Somadri Ghosh; Christophe Erneux
Journal:  J Lipid Res       Date:  2018-09-07       Impact factor: 5.922

2.  Cell-Dependent Pathogenic Roles of Filamin B in Different Skeletal Malformations.

Authors:  Huixiao Wu; Yanzhou Wang; Xinyu Chen; Yangyang Yao; Wanyi Zhao; Li Fang; Xiaoqing Sun; Ning Wang; Jie Jiang; Ling Gao; Jiajun Zhao; Chao Xu
Journal:  Oxid Med Cell Longev       Date:  2022-07-04       Impact factor: 7.310

3.  Dysregulation of Phosphoinositide 5-Phosphatases and Phosphoinositides in Alzheimer's Disease.

Authors:  Kunie Ando; Christophe Erneux; Mégane Homa; Sarah Houben; Marie-Ange de Fisenne; Jean-Pierre Brion; Karelle Leroy
Journal:  Front Neurosci       Date:  2021-02-25       Impact factor: 4.677

4.  Prenatal-onset INPPL1-related skeletal dysplasia in two unrelated families: Diagnosis and prediction of lethality.

Authors:  Iman Sabri Abumansour; Radiah Mahmoud Iskandarani; Alaa Edrees; Farrukh Javed; Fadwah Taher; Ghaidaa Farouk Hakeem
Journal:  Clin Case Rep       Date:  2021-05-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.